市場調査レポート
商品コード
1764857

北米の動脈血ガスキットの2031年までの市場予測:地域別分析 - シリンジタイプ別、タイプ別、用途別、アプリケーション別、ニードルゲージ別、シリンジ容量別、エンドユーザー別

North America Arterial Blood Gas Kits Market Forecast to 2031 - Regional Analysis - by Syringe Type, Type, Usage, Application, Needle Gauge, Syringe Volume, and End User


出版日
ページ情報
英文 158 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
北米の動脈血ガスキットの2031年までの市場予測:地域別分析 - シリンジタイプ別、タイプ別、用途別、アプリケーション別、ニードルゲージ別、シリンジ容量別、エンドユーザー別
出版日: 2025年04月17日
発行: The Insight Partners
ページ情報: 英文 158 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の動脈血ガスキット市場は、2023年に3億179万9,630米ドルと評価され、2031年には5億3,466万1,280米ドルに達すると予測され、2023年から2031年までのCAGRは7.4%と推定されます。

呼吸器系疾患の増加で北米の動脈血ガスキット市場が活性化

喘息、慢性閉塞性肺疾患(COPD)、肺炎などの呼吸器疾患は、世界各国の公的医療制度に大きな負担をかけています。感染症、喫煙、遺伝的要因は、深刻な呼吸器合併症を引き起こす可能性があります。慢性閉塞性肺疾患(COPD)は世界第4位の死因であり、2021年には350万人が死亡し、これは世界の全死亡の約5%に相当します。70歳未満のCOPD関連死の約90%は低・中所得国(LMIC)で発生しています。2021年、米国肺協会はCOPDを米国における主要な死因の第3位とし、同年に1,640万人以上がCOPDと診断されています。米国喘息・アレルギー財団によれば、2022年に米国で喘息にかかった人は2,600万人でした。米国国際児童緊急基金(UNICEF)によると、毎年10万人の子どもにつき1,400人近く、つまり71人に1人が肺炎と診断されています。呼吸障害を患う患者には、呼吸の問題や酸素不足がつきものです。動脈血ガス(ABG)検査は、血液中に溶けている酸素と炭酸ガスを測定するために行われます。この検査は、急性および慢性の呼吸器疾患を患う患者に提供されるケアの基礎となります。したがって、急性および慢性呼吸器疾患の急増が動脈血ガス検査キットの需要を促進しています。

北米の動脈血ガス検査キット市場概要

2023年に米国心不全学会(HFSA)が開始したHF Stats(SM)イニシアチブによると、一生のうちにHFを経験する人は4人に1人(~25%)と予想され、従来の5人に1人(~20%)から増加しています。HFSAのデータベースであるHF Statsによれば、20歳以上のアメリカ人のうち約670万人がHFに罹患しており、2030年にはその有病率は850万人に増加すると予想されています。HFの生涯リスクは24%に増加し、4人に1人が生涯HFに罹患すると予測されています。米国喘息・アレルギー財団によると、2022年には米国で2,600万人が喘息に罹患しており、世界で最も一般的な呼吸器疾患の一つです。呼吸器感染症はより重篤な疾患を引き起こし、入院や死亡に至る。死亡率は、虚弱や免疫老化といった加齢に関連した問題のため、若い人よりも高齢者に多く見られます。喘息は高齢者に多い呼吸器疾患のひとつです。2020年国勢調査によると、老年人口は2020年に米国総人口の5,580万人(16.8%)に達し、2012年から2050年にかけて大幅に増加すると予測されています。呼吸器疾患を患う患者は通常、酸素不足による呼吸の問題を経験するため、これらの人々は呼吸器疾患が健康に及ぼす影響について理解を深める必要があります。動脈血ガス分析は、患者の動脈血中の溶存酸素と二酸化炭素の含有量を、酸素分圧(PaO2)と二酸化炭素分圧(PaCO2)の形で評価します。PaCO2は換気状態(急性呼吸不全または慢性呼吸不全)に関する情報を、PaO2は酸素化状態に関する洞察を提供します。呼吸不全、急性呼吸窮迫症候群(ARDS)、喘息、糖尿病性ケトアシドーシス、腎尿細管性アシドーシス、心不全(HF)、先天性代謝性疾患など、動脈血ガス分析を必要とする慢性疾患の有病率が高まっていることが、動脈血ガスキット市場で米国が最大のシェアを占める主な要因です。さらに、この国の技術的進歩の面で確立された地位は、さまざまな動脈血ガスキットと関連技術の可用性に大きく寄与しています。

北米の動脈血ガスキット市場セグメンテーション

北米の動脈血ガスキット市場は、シリンジタイプ、タイプ、用途、アプリケーション、ニードルゲージ、シリンジ容量、エンドユーザー、国に分類されます。

シリンジタイプに基づき、北米の動脈血ガスキット市場はルアースリップシリンジとルアーロックシリンジに二分されます。2023年にはルアーロックシリンジセグメントがより大きな市場シェアを占めています。

タイプ別では、北米の動脈血ガスキット市場は通気型と非通気型に二分されます。2023年の市場シェアは、通気型が大きいです。

用途別では、北米の動脈血ガスキット市場はプリセットプランジャーモードと手動吸引に二分されます。プリセットプランジャーモードセグメントが2023年に大きな市場シェアを占めました。

アプリケーション別では、北米の動脈血ガスキット市場は体外診断と電解質分析に二分されます。2023年には体外診断分野がより大きな市場シェアを占めました。さらに、体外診断セグメントは、pH血液ガス、酸素含有量、その他にサブセグメント化されます。

ニードルゲージの観点では、北米の動脈血ガスキット市場は23G未満、23G~25G、25G以上に区分されます。23G~25Gのセグメントが2023年に最大の市場シェアを占めました。

シリンジ容量に基づいて、北米の動脈血ガスキット市場は1ml、3ml、その他に区分されます。3mlセグメントが2023年に最大の市場シェアを占めました。

エンドユーザー別では、北米の動脈血ガスキット市場は病院&クリニック、診断ラボ、その他に分類されます。病院&クリニックが2023年に最大の市場シェアを占めました。

国別では、北米の動脈血ガスキット市場は米国、カナダ、メキシコに区分されます。米国が2023年の北米の動脈血ガスキット市場シェアを独占しました。

Radiometer Medical ApS、Vyaire Medical Inc、Opti Medical Systems、Siemens Healthineers AG、AdvaCare Pharma USA LLC、Becton Dickinson and Co、ICU Medical Inc、SunMed Group Holdings LLC(AirLife)、Trudell Healthcare Solutions Inc、SARSTEDT AG &Co KG、Lepu Medical Technology Beijing Co Ltd.などが北米の動脈血ガスキット市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察
  • 市場の魅力

第3章 調査手法

  • 2次調査
  • 1次調査
    • 仮説の策定
    • マクロ経済要因分析
    • ファンデーション数値の開発
    • データの三角測量
    • 国レベルのデータ

第4章 北米の動脈血ガスキット市場情勢

  • PEST分析
  • 価格分析
  • 患者ポートフォリオ
  • COVID-19前後の市場シナリオ
  • 新興諸国における国内ABGシリンジ製造とブランドABGシリンジ製造の比較
  • 静脈ガス分析器vs動脈血液ガス分析器
  • 静脈ガス分析装置の動向

第5章 北米の動脈血ガスキット市場:主要市場力学

  • 市場促進要因
    • 呼吸器疾患の発生率の増加
    • 病院における緊急入院患者数の増加
  • 市場抑制要因
    • キットの高コストと動脈血サンプリングに伴う合併症
  • 市場機会
    • 新興国でのPOC診断の採用急増
  • 今後の動向
    • 安全で自動化されたキットの開発と電子カルテの統合
  • 促進要因と抑制要因の影響

第6章 動脈血ガスキット市場-北米分析

  • 北米の動脈血ガスキット市場概要
  • 動脈血液ガスキット市場収益、2021~2031年
  • 北米の動脈血ガスキット市場予測分析

第7章 北米の動脈血ガスキット市場分析:シリンジタイプ別

  • ルアースリップシリンジ
  • ルアーロックシリンジ

第8章 北米の動脈血ガスキット市場分析:タイプ別

  • ベント
  • ノンベント

第9章 北米の動脈血液ガスキット市場分析:用途別

  • プリセットプランジャーモード
  • 手動吸引

第10章 北米の動脈血液ガスキット市場分析:アプリケーション別

  • 体外診断
  • 電解質分析

第11章 北米の動脈血ガスキット市場分析:ニードルゲージ別

  • 23G未満
  • 23G以上25G未満
  • 25G以上

第12章 北米の動脈血ガスキット市場分析:シリンジ容量別

  • 1ml
  • 3ml
  • その他

第13章 北米の動脈血ガスキット市場分析:エンドユーザー別

  • 病院・クリニック
  • 診断研究所
  • その他

第14章 北米の動脈血ガスキット市場:国別分析

  • 北米市場概要
    • 北米
      • 米国
      • カナダ
      • メキシコ

第15章 競合情勢

  • 動脈血ガスキット市場:企業シェア分析~2023年
  • 血液ガス分析装置市場、企業シェア分析~2023年

第16章 業界情勢

  • 動脈血ガスキット市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第17章 企業プロファイル

  • Radiometer Medical ApS
  • Vyaire Medical Inc
  • Opti Medical Systems
  • Siemens Healthineers AG
  • AdvaCare Pharma USA LLC
  • Becton Dickinson and Co
  • ICU Medical Inc
  • SunMed Group Holdings LLC(AirLife)
  • Trudell Healthcare Solutions Inc
  • SARSTEDT AG & Co KG
  • Lepu Medical Technology Beijing Co Ltd

第18章 付録

図表

List Of Tables

  • Table 1. North America Arterial Blood Gas Kits Market Segmentation
  • Table 2. Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Table 3. Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Syringe Type
  • Table 4. Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Type
  • Table 5. Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Usage
  • Table 6. Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Application
  • Table 7. Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Needle Gauge
  • Table 8. Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Syringe Volume
  • Table 9. Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by End User
  • Table 10. North America: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Country
  • Table 11. United States: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Syringe Type
  • Table 12. United States: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Type
  • Table 13. United States: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Usage
  • Table 14. United States: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Application
  • Table 15. United States: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by In Vitro Diagnostics
  • Table 16. United States: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Needle Gauge
  • Table 17. United States: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Syringe Volume
  • Table 18. United States: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by 1 ml
  • Table 19. United States: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by 3 ml
  • Table 20. United States: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by End User
  • Table 21. Canada: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Syringe Type
  • Table 22. Canada: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Type
  • Table 23. Canada: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Usage
  • Table 24. Canada: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Application
  • Table 25. Canada: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by In Vitro Diagnostics
  • Table 26. Canada: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Needle Gauge
  • Table 27. Canada: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Syringe Volume
  • Table 28. Canada: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by 1 ml
  • Table 29. Canada: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by 3 ml
  • Table 30. Canada: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by End User
  • Table 31. Mexico: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Syringe Type
  • Table 32. Mexico: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Type
  • Table 33. Mexico: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Usage
  • Table 34. Mexico: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Application
  • Table 35. Mexico: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by In Vitro Diagnostics
  • Table 36. Mexico: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Needle Gauge
  • Table 37. Mexico: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by Syringe Volume
  • Table 38. Mexico: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by 1 ml
  • Table 39. Mexico: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by 3 ml
  • Table 40. Mexico: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand) - by End User
  • Table 41. Recent Organic Growth Strategies in Arterial Blood Gas Kits Market
  • Table 42. Recent Inorganic Growth Strategies in the Arterial Blood Gas Kits Market

List Of Figures

  • Figure 1. North America Arterial Blood Gas Kits Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Arterial Blood Gas Kits Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Arterial Blood Gas Kits Market Revenue (US$ Thousand), 2021-2031
  • Figure 6. Arterial Blood Gas Kits Market Share (%) - by Syringe Type (2023 and 2031)
  • Figure 7. Luer Slip Syringe: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 8. Luer Lock Syringe: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 9. Arterial Blood Gas Kits Market Share (%) - by Type (2023 and 2031)
  • Figure 10. Vented: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 11. Non-vented: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 12. Arterial Blood Gas Kits Market Share (%) - by Usage (2023 and 2031)
  • Figure 13. Pre-set Plunger Mode: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 14. Manual Aspiration: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 15. Arterial Blood Gas Kits Market Share (%) - by Application (2023 and 2031)
  • Figure 16. In Vitro Diagnostics: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 17. Electrolyte Analysis: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 18. Arterial Blood Gas Kits Market Share (%) - by Needle Gauge (2023 and 2031)
  • Figure 19. Less Than 23G: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 20. 23G to 25G: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 21. Greater Than 25G: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 22. Arterial Blood Gas Kits Market Share (%) - by Syringe Volume (2023 and 2031)
  • Figure 23. 1 ml: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 24. 3 ml: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 25. Others: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 26. Arterial Blood Gas Kits Market Share (%) - by End User (2023 and 2031)
  • Figure 27. Hospitals & Clinics: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 28. Diagnostic Laboratories: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 29. Others: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 30. North America Arterial Blood Gas Kits Market, by Key Country - Revenue (2023) (Thousand)
  • Figure 31. North America: Arterial Blood Gas Kits Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 32. United States: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 33. Canada: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 34. Mexico: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 35. Growth Strategies in Arterial Blood Gas Kits Market
目次
Product Code: TIPRE00024505

The North America arterial blood gas kits market was valued at US$ 3,01,799.63 thousand in 2023 and is expected to reach US$ 5,34,661.28 thousand by 2031; it is estimated to register a CAGR of 7.4% from 2023 to 2031.

Increasing Incidence of Respiratory Diseases Fuels North America Arterial Blood Gas Kits Market

Respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and pneumonia lead to a huge burden on public healthcare systems in various countries across the world. Infections, smoking, and genetic factors can cause serious respiratory complications. Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death globally, resulting in 3.5 million deaths in 2021, which represents about 5% of all deaths worldwide. Approximately 90% of COPD-related deaths among individuals under 70 years of age occur in low- and middle-income countries (LMIC). In 2021, the American Lung Association ranked COPD third among the leading causes of death in the US, and over 16.4 million people are diagnosed with the condition that year. As per the Asthma and Allergy Foundation of America, ~26 million people in the US had asthma in 2022. The United Nations International Children's Emergency Fund (UNICEF) stated that nearly 1,400 per 100,000 children, i.e., 1 case per 71 children, are diagnosed with pneumonia every year. Breathing issues and oxygen shortages are common in patients suffering from respiratory disorders. Arterial blood gas (ABG) tests are performed to measure oxygen and carbon dioxide gases dissolved in blood. The test serves as a basis of care delivered to patients suffering from acute and chronic respiratory disease. Thus, the surging incidence of acute and chronic respiratory diseases propels the demand for arterial blood gas test kits.

North America Arterial Blood Gas Kits Market Overview

According to the HF Stats (SM) initiative launched by the Heart Failure Society of America (HFSA) in 2023, 1 in 4 individuals (~25%) are expected to experience HF in their lifetime, a rise from the previous estimate of 1 in 5 individuals (~20%). As per HF Stats, an HFSA database, ~6.7 million Americans over 20 years of age suffer HF, and the prevalence is expected to rise to 8.5 million Americans by 2030. The lifetime risk of HF has increased to 24%, i.e., ~1 in every 4 individuals is projected to suffer from HF in their lifetime. According to the Asthma and Allergy Foundation of America, ~26 million people in the US had asthma in 2022, one of the world's most common respiratory diseases. Respiratory infections cause more severe disease, leading to hospitalizations or death. Mortality is more common in older persons than in younger ones due to age-related issues such as frailty and immunosenescence. Asthma is one of the most common respiratory diseases among senior citizens. According to the 2020 Census, the geriatric population reached 55.8 million (16.8%) of the total US population in 2020, and it is projected to rise significantly during 2012-2050. These individuals need a greater understanding of the impact of respiratory diseases on their health, as patients suffering from respiratory disorders usually experience breathing issues due to oxygen shortage. Arterial blood gas analysis evaluates dissolved oxygen and carbon dioxide content, in the form of partial oxygen pressures (PaO2) and partial carbon dioxide pressures (PaCO2), in the arterial blood of patients. PaCO2 gives information on ventilation status (acute or chronic respiratory failure), while PaO2 provides insights into oxygenation status. The growing prevalence of chronic diseases necessitating arterial blood gas analysis, including respiratory failure, acute respiratory distress syndrome (ARDS), asthma, diabetic ketoacidosis, renal tubular acidosis, heart failure (HF), and congenital metabolic diseases, is the major factor contributing to the largest share of the US in the arterial blood gas kits market. Moreover, the country's well-established position in terms of technological advancements contributes notably to the availability of various arterial blood gas kits and associated technologies.

North America Arterial Blood Gas Kits Market Revenue and Forecast to 2031 (US$ Thousand)

North America Arterial Blood Gas Kits Market Segmentation

The North America arterial blood gas kits market is categorized into syringe type, type, usage, application, needle gauge, syringe volume, end user, and country.

Based on syringe type, the North America arterial blood gas kits market is bifurcated into luer slip syringe and luer lock syringe. The luer lock syringe segment held a larger market share in 2023.

In terms of type, the North America arterial blood gas kits market is bifurcated into vented and non-vented. The vented segment held a larger market share in 2023.

By usage, the North America arterial blood gas kits market is bifurcated into pre-set plunger mode and manual aspiration. The pre-set plunger mode segment held a larger market share in 2023.

Based on application, the North America arterial blood gas kits market is bifurcated into in vitro diagnostics and electrolyte analysis. The in vitro diagnostics segment held a larger market share in 2023. Furthermore, the in vitro diagnostics segment is sub segmented into pH blood gas, oxygen content, and others.

In terms of needle gauge, the North America arterial blood gas kits market is segmented into less than 23G, 23G to 25G, and greater than 25G. The 23G to 25G segment held the largest market share in 2023.

Based on syringe volume, the North America arterial blood gas kits market is segmented into 1ml, 3ml, and others. The 3ml segment held the largest market share in 2023.

By end user, the North America arterial blood gas kits market is categorized into hospitals & clinics, diagnostic laboratories, and others. The hospitals & clinics held the largest market share in 2023.

Based on country, the North America arterial blood gas kits market is segmented into the US, Canada, and Mexico. The US dominated the North America arterial blood gas kits market share in 2023.

Radiometer Medical ApS, Vyaire Medical Inc, Opti Medical Systems, Siemens Healthineers AG, AdvaCare Pharma USA LLC, Becton Dickinson and Co, ICU Medical Inc, SunMed Group Holdings LLC (AirLife), Trudell Healthcare Solutions Inc, SARSTEDT AG & Co KG, and Lepu Medical Technology Beijing Co Ltd. are among the leading companies operating in the North America arterial blood gas kits market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. North America Arterial Blood Gas Kits Market Landscape

  • 4.1 PEST Analysis
  • 4.2 Pricing Analysis
  • 4.3 Patient Portfolio
  • 4.4 Pre and Post COVID 19 Market Scenario
  • 4.5 Domestic vs Branded ABG Syringes Manufacturing in Developing Countries
  • 4.6 Venous Gas Analysers vs Arterial Blood Gas Analyzers
  • 4.7 Venous Gas Analysers Trend:

5. North America Arterial Blood Gas Kits Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidence of Respiratory Diseases
    • 5.1.2 Rising Number of Admissions to Emergency Units in Hospitals
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Kits and Complications Associated with Arterial Blood Sampling
  • 5.3 Market Opportunities
    • 5.3.1 Surging Adoption of Point-of-Care Diagnostics in Emerging Countries
  • 5.4 Future Trends
    • 5.4.1 Development of Safe & Automated Kits and Integration of Electronic Medical Records
  • 5.5 Impact of Drivers and Restraints:

6. Arterial Blood Gas Kits Market - North America Analysis

  • 6.1 North America Arterial Blood Gas Kits Market Overview
  • 6.2 Arterial Blood Gas Kits Market Revenue (US$ Thousand), 2021-2031
  • 6.3 North America Arterial Blood Gas Kits Market Forecast Analysis

7. North America Arterial Blood Gas Kits Market Analysis - by Syringe Type

  • 7.1 Luer Slip Syringe
    • 7.1.1 Overview
    • 7.1.2 Luer Slip Syringe: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 7.2 Luer Lock Syringe
    • 7.2.1 Overview
    • 7.2.2 Luer Lock Syringe: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)

8. North America Arterial Blood Gas Kits Market Analysis - by Type

  • 8.1 Vented
    • 8.1.1 Overview
    • 8.1.2 Vented: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.2 Non-vented
    • 8.2.1 Overview
    • 8.2.2 Non-vented: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)

9. North America Arterial Blood Gas Kits Market Analysis - by Usage

  • 9.1 Pre-set Plunger Mode
    • 9.1.1 Overview
    • 9.1.2 Pre-set Plunger Mode: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 9.2 Manual Aspiration
    • 9.2.1 Overview
    • 9.2.2 Manual Aspiration: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)

10. North America Arterial Blood Gas Kits Market Analysis - by Application

  • 10.1 In Vitro Diagnostics
    • 10.1.1 Overview
    • 10.1.2 In Vitro Diagnostics: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 10.2 Electrolyte Analysis
    • 10.2.1 Overview
    • 10.2.2 Electrolyte Analysis: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)

11. North America Arterial Blood Gas Kits Market Analysis - by Needle Gauge

  • 11.1 Less Than 23G
    • 11.1.1 Overview
    • 11.1.2 Less Than 23G: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 11.2 23G to 25G
    • 11.2.1 Overview
    • 11.2.2 23G to 25G: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 11.3 Greater Than 25G
    • 11.3.1 Overview
    • 11.3.2 Greater Than 25G: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)

12. North America Arterial Blood Gas Kits Market Analysis - by Syringe Volume

  • 12.1 1 ml
    • 12.1.1 Overview
    • 12.1.2 1 ml: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 12.2 3 ml
    • 12.2.1 Overview
    • 12.2.2 3 ml: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 12.3 Others
    • 12.3.1 Overview
    • 12.3.2 Others: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)

13. North America Arterial Blood Gas Kits Market Analysis - by End User

  • 13.1 Hospitals & Clinics
    • 13.1.1 Overview
    • 13.1.2 Hospitals & Clinics: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 13.2 Diagnostic Laboratories
    • 13.2.1 Overview
    • 13.2.2 Diagnostic Laboratories: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 13.3 Others
    • 13.3.1 Overview
    • 13.3.2 Others: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)

14. North America Arterial Blood Gas Kits Market - Country Analysis

  • 14.1 North America Market Overview
    • 14.1.1 North America: Arterial Blood Gas Kits Market Breakdown, by Key Country, 2023 and 2031 (%)
      • 14.1.1.1 North America: Arterial Blood Gas Kits Market - Revenue and Forecast Analysis - by Country
      • 14.1.1.2 United States: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 14.1.1.2.1 United States: Arterial Blood Gas Kits Market Breakdown, by Syringe Type
        • 14.1.1.2.2 United States: Arterial Blood Gas Kits Market Breakdown, by Type
        • 14.1.1.2.3 United States: Arterial Blood Gas Kits Market Breakdown, by Usage
        • 14.1.1.2.4 United States: Arterial Blood Gas Kits Market Breakdown, by Application
          • 14.1.1.2.4.1 United States: Arterial Blood Gas Kits Market Breakdown, by In Vitro Diagnostics
        • 14.1.1.2.5 United States: Arterial Blood Gas Kits Market Breakdown, by Needle Gauge
        • 14.1.1.2.6 United States: Arterial Blood Gas Kits Market Breakdown, by Syringe Volume
          • 14.1.1.2.6.1 United States: Arterial Blood Gas Kits Market Breakdown, by 1 ml
          • 14.1.1.2.6.2 United States: Arterial Blood Gas Kits Market Breakdown, by 3 ml
        • 14.1.1.2.7 United States: Arterial Blood Gas Kits Market Breakdown, by End User
      • 14.1.1.3 Canada: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 14.1.1.3.1 Canada: Arterial Blood Gas Kits Market Breakdown, by Syringe Type
        • 14.1.1.3.2 Canada: Arterial Blood Gas Kits Market Breakdown, by Type
        • 14.1.1.3.3 Canada: Arterial Blood Gas Kits Market Breakdown, by Usage
        • 14.1.1.3.4 Canada: Arterial Blood Gas Kits Market Breakdown, by Application
          • 14.1.1.3.4.1 Canada: Arterial Blood Gas Kits Market Breakdown, by In Vitro Diagnostics
        • 14.1.1.3.5 Canada: Arterial Blood Gas Kits Market Breakdown, by Needle Gauge
        • 14.1.1.3.6 Canada: Arterial Blood Gas Kits Market Breakdown, by Syringe Volume
          • 14.1.1.3.6.1 Canada: Arterial Blood Gas Kits Market Breakdown, by 1 ml
          • 14.1.1.3.6.2 Canada: Arterial Blood Gas Kits Market Breakdown, by 3 ml
        • 14.1.1.3.7 Canada: Arterial Blood Gas Kits Market Breakdown, by End User
      • 14.1.1.4 Mexico: Arterial Blood Gas Kits Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 14.1.1.4.1 Mexico: Arterial Blood Gas Kits Market Breakdown, by Syringe Type
        • 14.1.1.4.2 Mexico: Arterial Blood Gas Kits Market Breakdown, by Type
        • 14.1.1.4.3 Mexico: Arterial Blood Gas Kits Market Breakdown, by Usage
        • 14.1.1.4.4 Mexico: Arterial Blood Gas Kits Market Breakdown, by Application
          • 14.1.1.4.4.1 Mexico: Arterial Blood Gas Kits Market Breakdown, by In Vitro Diagnostics
        • 14.1.1.4.5 Mexico: Arterial Blood Gas Kits Market Breakdown, by Needle Gauge
        • 14.1.1.4.6 Mexico: Arterial Blood Gas Kits Market Breakdown, by Syringe Volume
          • 14.1.1.4.6.1 Mexico: Arterial Blood Gas Kits Market Breakdown, by 1 ml
          • 14.1.1.4.6.2 Mexico: Arterial Blood Gas Kits Market Breakdown, by 3 ml
        • 14.1.1.4.7 Mexico: Arterial Blood Gas Kits Market Breakdown, by End User

15. Competitive Landscape

  • 15.1 Arterial Blood Gas Kits Market, Company Share Analysis - 2023
  • 15.2 Blood Gas Analyzers Market, Company Share Analysis - 2023
    • 15.2.1 Overview

16. Industry Landscape

  • 16.1 Overview
  • 16.2 Growth Strategies in Arterial Blood Gas Kits Market
  • 16.3 Organic Growth Strategies
    • 16.3.1 Overview
  • 16.4 Inorganic Growth Strategies
    • 16.4.1 Overview

17. Company Profiles

  • 17.1 Radiometer Medical ApS
    • 17.1.1 Key Facts
    • 17.1.2 Business Description
    • 17.1.3 Products and Services
    • 17.1.4 Financial Overview
    • 17.1.5 SWOT Analysis
    • 17.1.6 Key Developments
  • 17.2 Vyaire Medical Inc
    • 17.2.1 Key Facts
    • 17.2.2 Business Description
    • 17.2.3 Products and Services
    • 17.2.4 Financial Overview
    • 17.2.5 SWOT Analysis
    • 17.2.6 Key Developments
  • 17.3 Opti Medical Systems
    • 17.3.1 Key Facts
    • 17.3.2 Business Description
    • 17.3.3 Products and Services
    • 17.3.4 SWOT Analysis
    • 17.3.5 Key Developments
  • 17.4 Siemens Healthineers AG
    • 17.4.1 Key Facts
    • 17.4.2 Business Description
    • 17.4.3 Products and Services
    • 17.4.4 Financial Overview
    • 17.4.5 SWOT Analysis
    • 17.4.6 Key Developments
  • 17.5 AdvaCare Pharma USA LLC
    • 17.5.1 Key Facts
    • 17.5.2 Business Description
    • 17.5.3 Products and Services
    • 17.5.4 Financial Overview
    • 17.5.5 SWOT Analysis
    • 17.5.6 Key Developments
  • 17.6 Becton Dickinson and Co
    • 17.6.1 Key Facts
    • 17.6.2 Business Description
    • 17.6.3 Products and Services
    • 17.6.4 Financial Overview
    • 17.6.5 SWOT Analysis
    • 17.6.6 Key Developments
  • 17.7 ICU Medical Inc
    • 17.7.1 Key Facts
    • 17.7.2 Business Description
    • 17.7.3 Products and Services
    • 17.7.4 Financial Overview
    • 17.7.5 SWOT Analysis
    • 17.7.6 Key Developments
  • 17.8 SunMed Group Holdings LLC (AirLife)
    • 17.8.1 Key Facts
    • 17.8.2 Business Description
    • 17.8.3 Products and Services
    • 17.8.4 Financial Overview
    • 17.8.5 SWOT Analysis
    • 17.8.6 Key Developments
  • 17.9 Trudell Healthcare Solutions Inc
    • 17.9.1 Key Facts
    • 17.9.2 Business Description
    • 17.9.3 Products and Services
    • 17.9.4 Financial Overview
    • 17.9.5 SWOT Analysis
    • 17.9.6 Key Developments
  • 17.10 SARSTEDT AG & Co KG
    • 17.10.1 Key Facts
    • 17.10.2 Business Description
    • 17.10.3 Products and Services
    • 17.10.4 Financial Overview
    • 17.10.5 SWOT Analysis
    • 17.10.6 Key Developments
  • 17.11 Lepu Medical Technology Beijing Co Ltd
    • 17.11.1 Key Facts
    • 17.11.2 Business Description
    • 17.11.3 Products and Services
    • 17.11.4 Financial Overview
    • 17.11.5 SWOT Analysis
    • 17.11.6 Key Developments

18. Appendix

  • 18.1 About The Insight Partners